InnovAge Holding Corp. (INNV)
NASDAQ: INNV · IEX Real-Time Price · USD
6.07
+0.11 (1.85%)
At close: Jul 19, 2024, 4:00 PM
6.03
-0.04 (-0.66%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
InnovAge Holding Market Cap
InnovAge Holding has a market cap or net worth of $825.45 million as of July 22, 2024. Its market cap has decreased by -4.61% in one year.
Market Cap
825.45M
Enterprise Value
838.03M
1-Year Change
-4.61%
Ranking
Category
Stock Price
$6.07
Market Cap Chart
Since the IPO on March 4, 2021, InnovAge Holding's market cap has decreased from $2.80B to $825.45M, a decrease of -70.49%. That is a compound annual growth rate of -30.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 825.40M | 1.24% |
| Dec 29, 2023 | 815.30M | -16.24% |
| Dec 30, 2022 | 973.40M | 43.65% |
| Dec 31, 2021 | 677.60M | -75.77% |
| Mar 4, 2021 | 2.80B | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 873.34M |
| Perspective Therapeutics | 852.32M |
| Liquidia | 846.66M |
| Healthcare Services Group | 846.20M |
| GeneDx Holdings | 832.38M |
| Mesoblast | 825.11M |
| Cogent Biosciences | 823.23M |
| CureVac | 823.20M |